Diabetes mellitus, type 1 Trials in Aurora, United States
Conditions / Diabetes mellitus, type 1 / Aurora, United States
Diabetes mellitus, type 1 has been the subject of sustained clinical investigation across multiple research sites.
63 total trials for this combination
Showing top 10 of 63 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02443155 | A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function | COMPLETED | PHASE2 |
| NCT01835431 | A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT02670915 | Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes | COMPLETED | PHASE3 |
| NCT04200313 | The Insulin-Only Bionic Pancreas Pivotal Trial | COMPLETED | NA |
| NCT02098395 | The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes | COMPLETED | PHASE3 |
| NCT01513473 | A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT00982228 | Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes | COMPLETED | PHASE3 |
| NCT00322257 | Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes | TERMINATED | PHASE3 |
| NCT00773279 | Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics | COMPLETED | PHASE3 |
| NCT03808376 | PROMISE Study: An Evaluation of an Implantable Continuous Glucose Sensor up to 180 Days | COMPLETED | NA |